Helyx Industries S.p.A.

€0.62As of Sun 8 Nov 2026, 12:00 UTC
BIT:HLXHealthcare
Country Italy
PE (Fwd) •••
TSR 5Y CAGR (34.99%)
Div yield —
ROE (16.92%)
Biotechnology
Beta (5Y) 0.62
PE TTM —
TSR TTM (38.00%)
Mkt cap €16.40M
ROIC (18.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.703
13.32%
(26.44%)
Hold 5|5|1|6|11
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
13.26%
24.37%
31.71%
25.40%
Revenue€M
2.380
2.339
2.423
2.373
22.17%
14.03%
11.91%
4.76%
Peers (US$18.41M)
Cap (US$)
PE
22.58M
12.09x
17.74M
—
Capital
TTM
5Y
10Y
Leveragex
0.159
5.409
4.845
EBIT/Intx
0.988
0.529
0.330
Own earn%
(83.51)
(95.90)
(100.32)
Sh yield%
11.28
36.43
35.43
Owners
Insiders/Inst%
6.38
40.09
Short interest%
4.76
SBC / revenue%
3.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
5